Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History ARTL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics ARTL

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Artelo Biosciences Inc

ARTL
Current price
14.95 USD -0.43 USD (-2.80%)
Last closed 15.18 USD
ISIN US04301G2012
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 8 298 405 USD
Yield for 12 month +931.03 %
1Y
3Y
5Y
10Y
15Y
ARTL
21.11.2021 - 28.11.2021

Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. The company's product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated/ weight loss with cancer; and ART12.11, a synthetic cannabidiol cocrystal for the treatment anxiety, depression, post-traumatic stress disorder PTSD, epilepsy and insomnia, pain and inflammation, and other potential indications. It also offers ART26.12, a fatty acid binding protein 5 inhibitor for treating chemotherapy induced peripheral neuropathy, diabetic neuropathy, prostate cancer and breast cancer, pain, dermatologic conditions, and anxiety disorders. The company was formerly known as Reactive Medical Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California. Address: 505 Lomas Santa Fe, Solana Beach, CA, United States, 92075

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

6.00 USD

P/E Ratio

Dividend Yield

Financials ARTL

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures ARTL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

EBITDA -7 440 756 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -89.21 %
PEG Ratio
Return On Equity TTM -190.70 %
Wall Street Target Price 6.00 USD
Revenue TTM
Book Value 1.19 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -17.94 USD
Diluted Eps TTM -17.94 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation ARTL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA 1.22
Price Book MRQ 15.55

Technical Indicators ARTL

For 52 Weeks

4.92 USD 28.60 USD
50 Day MA 8.30 USD
Shares Short Prior Month 11 794
200 Day MA 7.00 USD
Short Ratio 1.00
Shares Short 20 410
Short Percent 2.18 %